Why the study?
Guidelines recommend selective beta1-blockers in patients with heart failure and COPD, but low adherence to guidelines has been observed across clinical settings.
Population
942 older patients with HF in the REPOSI register
Comparison
Patients with HF and COPD vs patients with HF alone
Design
Registry-based survey
Authors
Loading...
Beta-blocker underuse in HF with COPD was observed; leaves open whether targeted education or trials improve prescribing and outcomes.
Despite guideline recommendations, beta-blockers are significantly underused in older hospitalized patients with heart failure and concomitant COPD.
Arcoraci et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: